Sari la conținut
Coșul meu

Produse destinate exclusiv cercetării. Nu se utilizează în diagnostic sau tratament.

Anti-Rituximab Antibody [MB2A4] (HRP)

Pe scurt

Anti-Rituximab Antibody [MB2A4] (HRP) este un anticorp monoclonal de șobolan împotriva țintei Rituximab. Este validat pentru ELISA, are izotipul IgG2a și este conjugat cu HRP. Se livrează în mărimea 100µg, la prețul de 6.056,05 lei cu TVA.

Produse destinate exclusiv cercetării. Nu se utilizează în diagnostic sau tratament.

Descriere

Rat monoclonal [MB2A4] antibody to Rituximab (HRP).

Specificații

Mărime
100µg
Țintă
Rituximab
Applications
ELISA
Conjugate
HRP
Host
Rat
Clonality
Monoclonal
Product form
Liquid
Concentration
1 mg/ml
Isotype
IgG2a
Recommended dilutions
ELISA: 1:20,000 - 1:200,000
Clonă
MB2A4
Imunogen
F(ab')2 fragment of Rituximab.
Specificitate
This antibody recognises the monoclonal antibody drug rituximab. The antibody can be used to measure the levels of rituximab and biosimilar products in bioanalytical assays. recognises ocrelizumab, a second-generation humanized anti-CD20 antibody that binds to an epitope on CD20 that is identical or overlapping with the rituximab epitope. Clone MB2A4 has been used in ELISA to monitor the levels of rituximab in patient serum following therapy (Cragg et al. 2004 and Hampson et al. 2010).Clone MB2A4 has been used to detect rituximab bound to the surface of the Raji B cell line, however detection of rituximab bound in vivo to B-CLL cells has not been demonstrated. It is possible that complement deposition on rituximab opsonised cells inhibits binding of the Anti-Rituximab Antibody to cell bound rituximab. Inhibition experiments carried out with Daudi cells demonstrated that this antibody is inhibitory at a ratio of 5:1 antibody:rituximab, but does not inhibit rituximab binding to CD20 at a ratio of 1:1.Rituximab (reference product branded as Rituxan) is a chimeric mouse/human monoclonal antibody approved for the treatment of certain autoimmune diseases and cancer, including non-Hodgkin's lymphoma, chronic lymphocytic leukemia and rheumatoid arthritis. The antibody is specific for the cell surface protein CD20, which is widely expressed on B cells. Through three different mechanisms of action it eliminates B cells from the body, enabling the development of a new population of healthy B cells.View a summary of all Anti-Rituximab Antibodies.

Documentație

Produse similare

Ai nevoie de ajutor?

Nu găsești produsul potrivit? Scrie-ne cerințele și îți răspundem cu o recomandare și un preț.

Solicită consultanță

Achiziții publice

Suntem înregistrați în SEAP și livrăm către instituții publice, cu documentație completă.

Cum cumperi prin SEAP →

Contact